Industry snapshot
Key public data points
Historical & forecast
Base year 2025. Each series is official through its own latest government-data year (shown in the legend on each chart), and years beyond that are Claight estimates. As of July 2026 the current year is still in progress (2026 annual data is not yet published), so the forecast runs to 2030.
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Industry Definition and Scope
What does the Alternative & Other Health Services in Australia industry cover?
This industry encompasses independent practitioners and units providing allied and alternative medical treatments that sit outside standard general medical practices. Services typically include acupuncture, aromatherapy, naturopathy, traditional Chinese medicine, homeopathy, and custom nutrition therapies. The sector relies on self-employed specialists and boutique clinics focused on holistic patient care.
- •Primary activities are mapped under the official Australian classification system for individual allied and natural therapies.
- •Includes specialized traditional practices such as ayurvedic medicine, indigenous traditional medicine, and clinical psychology.
- •Excludes primary weight loss center operations and conventional general practice or specialist medical services.
Market Structure and Operators
Who operates in the industry and how is it structured?
The sector exhibits a highly dispersed organizational landscape dominated by independent practitioners and localized small businesses. Official data submitted to the Australian Treasury notes the presence of 22,649 natural health practitioner businesses across the nation. This distributed profile allows for widespread geographic availability but limits centralized market consolidation.
- •Natural health practitioner businesses nationwide employed approximately 34,467 people according to sector figures.
- •The market is heavily populated by sole traders and small partnerships operating local clinical spaces.
- •Services are highly customized and non-standardized, varying significantly by practitioner training and specific modality.
Demand Drivers
What drives demand in the industry?
Consumer preference for preventative medicine and the management of long-term health concerns serve as primary drivers for alternative treatments. Data reveals that approximately 70% of the Australian population utilizes complementary medicines or therapies to support their well-being. Additionally, over 50% of Australians deal with some form of chronic condition, motivating individuals to seek out ancillary natural wellness protocols.
- •Around two in three Australians engage with complementary therapies or products annually to address individual health goals.
- •Increasing out-of-pocket healthcare expenditures prompt consumers to allocate discretionary funds toward wellness options.
- •An aging demographic suffering from age-related ailments drives continuous demand for long-term chronic care alternatives.
Competitive Landscape and Notable Public Companies
Who are the notable companies in the industry?
Competition in the delivery of services is primarily localized and depends heavily on regional practitioner reputation and professional networks. The broader supply and product ecosystem includes both localized commercial operations and highly active publicly listed corporations. These major entities supply products, practitioner-only lines, and technical platforms that underpin the delivery of clinical natural therapies.
- •Biome Australia Limited (ASX:BIO) is an active listed entity specializing in targeted microbiome and natural health solutions.
- •Immuron Limited (ASX:IMC) develops and markets targeted listed medicines and protective immune supplements locally.
- •Elixinol Wellness Limited (ASX:EXL) builds and administers an expanded portfolio of premium consumer nutrition and natural wellness brands.
- •ParagonCare Limited provides comprehensive wholesale distribution channels and clinical logistics support to natural health practices via its specialized complementary medicine unit.
Recent Trends and Outlook
What are the recent trends and outlook?
The alternative health sector is adapting to major funding changes following structural modifications in private medical coverage. In April 2019, the Australian Government removed 16 natural therapy modalities from private health insurance rebate eligibility, altering the consumer cost dynamic. Despite this regulatory shift, underlying consumer participation remains resilient as practitioners digitize services and incorporate direct-to-patient fulfillment tools.
- •Practitioners increasingly adopt digital ordering networks, such as ParagonCare Prescribe, to streamline customized direct-to-patient remedies.
- •Consumer out-of-pocket spending on complementary wellness alternatives has grown steadily to exceed billions annually.
- •Strategic alliances between clinical researchers and local practitioners are expanding evidence-based integration within traditional healthcare setups.
Regulation and Compliance
How is the industry regulated?
The manufacturing, labeling, and commercial sale of complementary remedies are strictly governed by federal medical watchdogs. The Therapeutic Goods Administration (TGA) evaluates product safety, dictating whether items are formally Registered or Listed on the Australian Register of Therapeutic Goods. Unregistered practitioners are also subject to state-level health complaints commissioners and national codes of conduct.
- •Compliant products are explicitly required to display official identifiers, such as 'AUST L' or 'AUST R', on their public packaging.
- •Practitioners must adhere to standard advertising codes regarding therapeutic claims to prevent misleading consumers.
- •The Australian Health Practitioner Regulation Agency (AHPRA) maintains statutory oversight for specific registered allied professions, while voluntary trade bodies manage self-regulated fields.
Sources
Government, statistical and trade sources used for this Claight analysis.
- The Treasury, Pre-Budget Submissions 2021-22 ·
- The Treasury, Pre-Budget Submissions 2022-23 ·
- Australian Bureau of Statistics, ANZSIC 2006 (Revision 2.0) ·
- Therapeutic Goods Administration (TGA) Guidelines
Claight analysis of public industry data.